Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Case Rep ; 18: 313-316, 2017 Mar 28.
Article in English | MEDLINE | ID: mdl-28348360

ABSTRACT

BACKGROUND Deep vein thrombosis (DVT) is a type of venous thromboembolism with diverse clinical and environmental risk factors. Very few cases of DVT with multiple high risk factors have been reported. Here, we report an uncommon DVT case with multiple etiological causes, including appendicitis/appendectomy, morbid obesity, immobilization, positive phosphatidylserine IgG, and heterozygous factor V Leiden mutation. CASE REPORT A 43-year-old female was brought to the emergency room because of 2-week history of pain and swelling and ultrasound revealing evidence of DVT in the right leg. One month ago, she underwent an exploratory laparotomy because of subacute appendicitis. After surgery, the patient stayed at home in bed with very limited activity. She did not have a cough, hemoptysis, chest pain, or shortness of breath. She was morbidly obese, and had a past medical history of diabetes, hypertension, and hyperlipidemia. A full coagulation workup was completed, including Protein C, Protein S, and antiphospholipid antibody, as well as factor V and prothrombin gene mutation screen. Her D-dimer was positive. Computed tomography (CT) angiography of the lungs ruled out major emboli but was unable to rule out minor emboli. A heterozygous factor V Leiden R506Q mutation was detected. Of interest was a significantly positive phosphatidylserine IgG with a value of over 42. She was started with enoxaparin (120 mg, twice a day), and warfarin was added on day 2 when pulmonary embolism was ruled out by CT angiography. The International Normalized Ratio (INR) was monitored daily to adjust warfarin dose. CONCLUSIONS Multiple etiological factors present in this patient may have contributed to her lower-limb DVT, including appendicitis/appendectomy, morbid obesity, immobilization, positive phosphatidylserine IgG, and factor V Leiden mutation. Therefore, it is important to follow the complete workup for hypercoagulable states. This can help with diagnosis and therapy, and also give insight into the pathogenicity, which can help with prevention of recurrence and severe complications of DVT.


Subject(s)
Lower Extremity/blood supply , Venous Thrombosis/etiology , Adult , Appendectomy/adverse effects , Factor V/genetics , Female , Humans , Immobilization/adverse effects , Immunoglobulin G/blood , Mutation , Obesity, Morbid/complications , Phosphatidylserines/immunology , Risk Factors
2.
Blood Coagul Fibrinolysis ; 27(6): 720-3, 2016 Sep.
Article in English | MEDLINE | ID: mdl-26650456

ABSTRACT

The study highlights pulmonary embolism and deep vein thrombosis by methylene tetrahydrofolate reductase (MTHFR) deficiency-related hyperhomocysteinemia occurring in rare locations of left veins superior to the heart extensively. A 59-year-old white man with history of leg pain, smoking, weight loss, benign prostatic hyperplasia, lipoma and panic attack presented with shortness of breath and chest pain for 2 days precipitated by not feeling well for months. The diagnostic workup revealed pulmonary embolism and deep vein thrombosis in the left subclavian vein which extended throughout the left brachiocephalic vein to the superior vena cava and left jugular vein. Further workup showed moderate hyperhomocysteinemia with normal levels of vitamin B6, B12 and folic acid. Methylene tetrahydrofolate reductase genetic study found the patient to be homozygous for G677T variant. He was started on low-molecular-weight heparin and was discharged on oral anticoagulant. No recurrent thrombotic episodes were witnessed after 4 months of follow-up after discharge.


Subject(s)
Homocystinuria/diagnosis , Hyperhomocysteinemia/diagnosis , Methylenetetrahydrofolate Reductase (NADPH2)/deficiency , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Muscle Spasticity/diagnosis , Mutation , Pulmonary Embolism/diagnosis , Upper Extremity Deep Vein Thrombosis/diagnosis , Anticoagulants/therapeutic use , Heparin, Low-Molecular-Weight/therapeutic use , Homocystinuria/blood , Homocystinuria/complications , Homocystinuria/drug therapy , Homozygote , Humans , Hyperhomocysteinemia/blood , Hyperhomocysteinemia/complications , Hyperhomocysteinemia/drug therapy , Male , Methylenetetrahydrofolate Reductase (NADPH2)/blood , Middle Aged , Muscle Spasticity/blood , Muscle Spasticity/complications , Muscle Spasticity/drug therapy , Psychotic Disorders/blood , Psychotic Disorders/complications , Psychotic Disorders/diagnosis , Psychotic Disorders/drug therapy , Pulmonary Embolism/blood , Pulmonary Embolism/complications , Pulmonary Embolism/drug therapy , Upper Extremity Deep Vein Thrombosis/blood , Upper Extremity Deep Vein Thrombosis/complications , Upper Extremity Deep Vein Thrombosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...